Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Human Factors

Date Submitted: Jan 1, 2026
Date Accepted: Jun 23, 2026

The final, peer-reviewed published version of this preprint can be found here:

Japanese Health Information Technology Usability Evaluation Scale for Sexually Transmitted Infection–Related Chatbots: Development and Psychometric Validation Study

Hato T, Ishikawa H, Todo K, Harada K, Yoshikawa A, Fukuda Y, Schnall R

Japanese Health Information Technology Usability Evaluation Scale for Sexually Transmitted Infection–Related Chatbots: Development and Psychometric Validation Study

JMIR Hum Factors 2026;13:e90483

DOI: 10.2196/90483

PMID: 42490573

Development and Psychometric Validation of the Japanese Health Information Technology Usability Evaluation Scale (Health-ITUES) for STI-Related Chatbots

  • Tomoko Hato; 
  • Hirono Ishikawa; 
  • Kense Todo; 
  • Keisuke Harada; 
  • Atsuhi Yoshikawa; 
  • Yoshiharu Fukuda; 
  • Rebecca Schnall

ABSTRACT

Background:

The rapid expansion of mobile technology has accelerated the integration of health applications and conversational artificial intelligence into clinical and public health practices. To ensure these tools are effective and sustainable, usability evaluations and early user engagement during development are essential The Health Information Technology Usability Evaluation Scale (Health-ITUES) is a validated flexible usability assessment instrument that is available in multiple languages and applicable across diverse contexts. However, a Japanese version of this scale has yet to be developed.

Objective:

This study aimed to translate the Health-ITUES into Japanese, evaluate its validity, and contribute to the usability assessment of mobile health (mHealth tools), which are expected to expand across diverse contexts.

Methods:

We developed a Japanese version of the Health-ITUES using a chatbot under development as a consultation tool for young women regarding sexually transmitted infections (STIs). First, the original scale was customized to reflect the chatbot’s specific purpose and intended usage context. Following established translation guidelines, we conducted forward translation from English to Japanese, back-translation, expert review, and reconciliation. We then evaluated the reliability and validity of the Japanese version in 301 young women.

Results:

The Japanese version of Health-ITUES demonstrated high internal consistency (Cronbach’s α=0.85–0.98). Confirmatory factor analysis supported acceptable construct validity (RMSEA=0.10, CFI > 0.90). Additionally, the Health-ITUES scores showed strong correlations with satisfaction and usage intention for the tool (r=0.779 and 0.797, respectively).

Conclusions:

The Japanese version of the Health-ITUES demonstrated sufficient reliability and validity in a hypothetical STI concern scenario among young women. Given that the Health-ITUES has previously been validated in Human immunodeficiency virus (HIV) patients, dysmenorrhea management, and home healthcare, it is promising as a widely applicable usability assessment tool for mHealth technologies across health conditions.


 Citation

Please cite as:

Hato T, Ishikawa H, Todo K, Harada K, Yoshikawa A, Fukuda Y, Schnall R

Japanese Health Information Technology Usability Evaluation Scale for Sexually Transmitted Infection–Related Chatbots: Development and Psychometric Validation Study

JMIR Hum Factors 2026;13:e90483

DOI: 10.2196/90483

PMID: 42490573

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.